Literature DB >> 11231743

Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome.

N Sekine, T Motokura, T Oki, Y Umeda, N Sasaki, M Hayashi, H Sato, T Fujita, T Kaneko, Y Asano, K Kikuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11231743     DOI： 10.1001/jama.285.9.1153

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Pathogenesis of fulminant type 1 diabetes.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Rev Diabet Stud       Date:  2007-02-10

2.  Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study.

Authors:  Michiel B Haeseker; Evelien Pijpers; Nicole Htm Dukers-Muijrers; Patty Nelemans; Christian Jpa Hoebe; Cathrien A Bruggeman; Annelies Verbon; Valère J Goossens
Journal:  Immun Ageing       Date:  2013-07-23       Impact factor: 6.400

Review 3.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

Review 4.  Type 1 diabetes in Japan.

Authors:  E Kawasaki; N Matsuura; K Eguchi
Journal:  Diabetologia       Date:  2006-03-28       Impact factor: 10.122

5.  T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes.

Authors:  R Kotani; M Nagata; A Imagawa; H Moriyama; H Yasuda; J Miyagawa; T Hanafusa; K Yokono
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

6.  Type 1 diabetes mellitus in a child with phenobarbital hypersensitivity syndrome.

Authors:  C C Zou; L Liang; J F Fu
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

7.  Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae.

Authors:  Rebecca J Brown; Kristina I Rother; Henry Artman; Mary Gail Mercurio; Roger Wang; R John Looney; Edward W Cowen
Journal:  Arch Dermatol       Date:  2009-01

8.  Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus.

Authors:  Megu Yamaguchi Baden; Akihisa Imagawa; Hiromi Iwahashi; Iichiro Shimomura; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Hiroshi Kajio; Eiji Kawasaki; Yumiko Kawabata; Akira Shimada; Kazuma Takahashi; Shoichiro Tanaka; Kazuki Yasuda; Hisafumi Yasuda; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  Diabetol Int       Date:  2015-12-29

Review 9.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

10.  Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor-related and conventional.

Authors:  Akihisa Imagawa
Journal:  J Diabetes Investig       Date:  2020-12-07       Impact factor: 4.232
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.